Arcturus Therapeutics Holdings (ARCT) FCF Margin Growth (3y) (2021 - 2026)
Arcturus Therapeutics Holdings (ARCT) FCF Margin Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 10,029.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 723.00 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Arcturus Therapeutics Holdings | 217.14 Mn | 5.76 Mn | - | -89,847.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -89,847.00 |
| Dec 31, 2025 | -32,509.00 |
| Sep 30, 2025 | 23,384.00 |
| Jun 30, 2025 | 11,418.00 |
| Mar 31, 2025 | 85,534.00 |
| Dec 31, 2024 | 69,364.00 |
| Sep 30, 2024 | 69,859.00 |
| Jun 30, 2024 | 159,941.00 |
| Mar 31, 2024 | 201,521.00 |
| Dec 31, 2023 | 25,232.00 |
| Sep 30, 2023 | 64,845.00 |
| Jun 30, 2023 | 84,012.00 |
| Mar 31, 2023 | 40,870.00 |
| Dec 31, 2022 | 36,219.00 |
| Sep 30, 2022 | -23,340.00 |
| Jun 30, 2022 | -22,768.00 |
| Mar 31, 2022 | -84,791.00 |
| Dec 31, 2021 | -60,166.00 |
| Sep 30, 2021 | -55,651.00 |